Pharmaceutical Regulatory Affairs

Pharmaceutical Regulatory Affairs, or Pharma Regulatory Affairs, refers to the professionals who maintain regulations from within the assiduity. The pharmaceutical assiduity is the most regulated of all diligence. Regulatory affairs professionals are crucial, but maybe overlooked, players in medicine development. The department of Regulatory Affairs is established to cover public health, by covering and controlling the safety and efficacy of medicines within several disciplines including medicinal, veterinary medicines, agrochemicals, cosmetics, medical devices, fungicides, and reciprocal medicines. The civil controllers are The Office of the Comptroller of the Currency (OCC) The Federal Reserve System.

    Related Conference of Pharmaceutical Regulatory Affairs

    February 24-25, 2025

    2nd International Conference on Pharmacognosy

    Madrid, Spain
    February 27-28, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    March 10-11, 2025

    35th Annual European Pharma Congress

    Rome, Italy
    April 14-15, 2025

    18th European Biosimilars Congress

    Paris, France
    April 24-25, 2025

    18th World Drug Delivery Summit

    London, UK
    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Pharmaceutical Regulatory Affairs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in